{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:32:52Z","timestamp":1753893172209,"version":"3.41.2"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Transplant."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The clinical characteristics of <jats:italic>de novo<\/jats:italic> inflammatory bowel disease (dnIBD) diagnosed after solid organ transplant (SOT) are not well-described, particularly since the advent of biologic therapy for treatment of IBD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a single-center, retrospective review of SOT recipients between 2010 and 2022 at the University of Minnesota Medical Center who were diagnosed with IBD after transplant.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 89 patients at our center with IBD and a history of SOT, five (5.6%) patients were diagnosed with IBD post-transplant (three liver, one kidney, and one simultaneous liver and kidney): three patients were female and four were Caucasian. Mean age at transplant and IBD diagnosis were 46.7 and 49.4 years respectively. Indication for transplant were alcohol-related cirrhosis (<jats:italic>n<\/jats:italic>\u2009=\u20092), idiopathic fulminant hepatic failure (<jats:italic>n<\/jats:italic>\u2009=\u20091), metabolic dysfunction-associated steatotic liver disease (<jats:italic>n<\/jats:italic>\u2009=\u20091), and IgA nephropathy (<jats:italic>n<\/jats:italic>\u2009=\u20091). Four patients were diagnosed with ulcerative colitis (UC) and one with Crohn's disease (CD). Three patients (all with UC) required escalation to a biologic therapy. Four patients were in clinical remission from IBD at last follow-up, one patient required IBD surgery, while there was no rejection and no deaths following IBD diagnosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>dnIBD post-SOT is uncommon, while newer IBD therapies may be safe and effective. Further study is required to better understand the natural history and IBD outcomes of this population relative to non-SOT patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/frtra.2024.1483943","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T06:22:14Z","timestamp":1736317334000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnosis and management of de novo inflammatory bowel disease after solid organ transplantation in the era of biologic therapy: a case series"],"prefix":"10.3389","volume":"3","author":[{"suffix":"Jr","given":"Willie Mohammed","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byron P.","family":"Vaughn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.17235\/reed.2020.7361\/2020","article-title":"Inflammatory bowel disease and solid organ transplantation","volume":"112","author":"Martinez Montiel","year":"2020","journal-title":"Rev Esp Enferm Dig"},{"key":"B2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.25122\/jml-2018-0075","article-title":"A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease","volume":"12","author":"Seyedian","year":"2019","journal-title":"J Med Life"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.3748\/wjg.v23.i18.3214","article-title":"Inflammatory bowel disease in liver transplanted patients","volume":"23","author":"Filipec Kanizaj","year":"2017","journal-title":"World J Gastroenterol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.3748\/wjg.v20.i13.3525","article-title":"Clinical management of inflammatory bowel disease in the organ recipient","volume":"20","author":"Indriolo","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1111\/j.1600-6143.2006.01333.x","article-title":"Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease","volume":"6","author":"Verdonk","year":"2006","journal-title":"Am J Transplant"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1053\/j.gastro.2020.01.006","article-title":"AGA clinical practice guidelines on the management of moderate to severe ulcerative colitis","volume":"158","author":"Feuerstein","year":"2020","journal-title":"Gastroenterology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.3748\/wjg.v26.i28.3998","article-title":"Secondary causes of inflammatory bowel diseases","volume":"26","author":"Ghouri","year":"2020","journal-title":"World J Gastroenterol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.clim.2008.06.011","article-title":"Inflammatory bowel disease following solid organ transplantation","volume":"128","author":"Hampton","year":"2008","journal-title":"Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000538334","article-title":"de novo inflammatory bowel disease in kidney transplant recipients: a single-center case series study","volume":"9","author":"Ogata","year":"2024","journal-title":"Inflamm Intest Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1093\/ibd\/izz059","article-title":"The role of early biologic therapy in inflammatory bowel disease","volume":"25","author":"Berg","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.gtc.2006.09.002","article-title":"Infliximab in ulcerative colitis","volume":"35","author":"Aberra","year":"2006","journal-title":"Gastroenterol Clin North Am"},{"key":"B13","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/ibd\/izad108","article-title":"Safety of biologic and small molecule therapy for inflammatory bowel disease among solid organ transplant recipients: systematic review and meta-analysis","volume":"30","author":"Taneja","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","article-title":"Inflammatory bowel disease: pathogenesis","volume":"20","author":"Zhang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.suc.2019.08.001","article-title":"Inflammatory bowel disease presentation and diagnosis","volume":"99","author":"Flynn","year":"2019","journal-title":"Surg Clin North Am"},{"key":"B16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.5500\/wjt.v3.i4.113","article-title":"Essential concept of transplant immunology for clinical practice","volume":"3","author":"Kumbala","year":"2013","journal-title":"World J Transplant"},{"key":"B17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.mayocp.2018.09.013","article-title":"Mechanisms of disease: inflammatory bowel diseases","volume":"94","author":"Ramos","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"B18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1681\/ASN.2020060848","article-title":"Inflammatory bowel disease is more common in patients with IgA nephropathy and predicts progression of ESKD: a Swedish population-based cohort study","volume":"32","author":"Rehnberg","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"704","DOI":"10.2215\/CJN.0000000000000457","article-title":"Association of inflammatory bowel disease with incident IgA nephropathy","volume":"19","author":"Nakayama","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1159\/000534062","article-title":"Kidney biopsy findings and clinical outcomes of US veterans with inflammatory bowel disease","volume":"3","author":"Ravipati","year":"2023","journal-title":"Glomerular Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e13397","DOI":"10.1111\/tid.13397","article-title":"The alteration of the gut microbiome by immunosuppressive agents used in solid organ transplantation","volume":"23","author":"Gibson","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.5500\/wjt.v12.i7.157","article-title":"Gut microbiome dysbiosis in the setting of solid organ transplantation: what we have gleaned from human and animal studies","volume":"12","author":"Sharma","year":"2022","journal-title":"World J Transplant"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e6774","DOI":"10.7759\/cureus.6774","article-title":"Mycophenolate-induced colitis: a case report with focused review of literature","volume":"12","author":"Farooqi","year":"2020","journal-title":"Cureus"},{"key":"B24","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.cgh.2022.07.032","article-title":"Comparative risk of serious infections with biologic agents and oral small molecules in inflammatory bowel diseases: a systematic review and meta-analysis","volume":"21","author":"Solitano","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12876-022-02347-1","article-title":"Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"22","author":"Peyrin-Biroulet","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.semarthrit.2021.08.013","article-title":"Safety of biologic treatments in solid organ transplant recipients: a systematic review","volume":"51","author":"Meyer","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1056\/NEJMoa1905725","article-title":"Vedolizumab versus adalimumab for moderate-to-severe ulcerative colitis","volume":"381","author":"Sands","year":"2019","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/gutjnl-2014-307127","article-title":"Vedolizumab affects antibody responses to immunisation selectively in the gastrointestinal tract: randomised controlled trial results","volume":"64","author":"Wyant","year":"2015","journal-title":"Gut"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e0135807","DOI":"10.1371\/journal.pone.0135807","article-title":"Solid organ transplantation in patients with inflammatory bowel diseases (IBD): analysis of transplantation outcome and IBD activity in a large single center cohort","volume":"10","author":"Schnitzler","year":"2015","journal-title":"PLoS One"},{"key":"B30","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3109\/00365521.2015.1093167","article-title":"The changing face of Crohn\u2019s disease: a population-based study of the natural history of Crohn\u2019s disease in \u00d6rebro, Sweden 1963\u20132005","volume":"51","author":"Zhulina","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1136\/gut.2009.202101","article-title":"Natural history of Crohn\u2019s disease in a population-based cohort from Cardiff (1986\u20132003): a study of changes in medical treatment and surgical resection rates","volume":"59","author":"Ramadas","year":"2010","journal-title":"Gut"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/ecco-jcc\/jjad030","article-title":"Non-hepatic solid organ transplant in patients with inflammatory bowel disease: an ECCO CONFER multicentre case series","volume":"17","author":"Ribaldone","year":"2023","journal-title":"J Crohn\u2019s Colitis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"765474","DOI":"10.3389\/fmed.2021.765474","article-title":"Treatment of inflammatory bowel disease: a comprehensive review","volume":"8","author":"Cai","year":"2021","journal-title":"Front Med"}],"container-title":["Frontiers in Transplantation"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frtra.2024.1483943\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T06:22:16Z","timestamp":1736317336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frtra.2024.1483943\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":33,"alternative-id":["10.3389\/frtra.2024.1483943"],"URL":"https:\/\/doi.org\/10.3389\/frtra.2024.1483943","relation":{},"ISSN":["2813-2440"],"issn-type":[{"type":"electronic","value":"2813-2440"}],"subject":[],"published":{"date-parts":[[2025,1,8]]},"article-number":"1483943"}}